ProBiotix Health has entered into a commercial partnership with Deutsch-Pharm to supply its cardiovascular health-supporting probiotics.
The probiotics specialist will leverage Deutsch Pharm's connections in the Ukrainian market to expand its reach in the country, with the aim to expand its global footprint further subsequent to this.
ProBiotix Health's cardiovascular and metabolic health products should be fully commercialised by Q1 of 2025.
As part of the agreement, Deutsch Pharm will initially distribute two of ProBiotix's probiotic solutions.
This includes YourBiotixX3, designed to lower cholesterol, and YourBiotixVH, which targets general vascular health — including the cardiovascular system.
Currently, Deutsch-Pharm works with more than 9,000 customers and partners in Ukraine, so ProBiotix will likely experience significant expansion in the region.
Following this agreement, both YourBiotixX3 and YourBiotixVH are the first natural, preventative, and clinically documented dietary supplements that are available to consumers in Ukraine.
Steen Andersen, CEO of ProBiotix, commented: “We are excited for the opportunity to work with a leading company like Deutsch-Pharm to open up this region for our probiotic products based on LPLDL."
“Through this cooperation, our products will become available to Ukrainian consumers through brick-and-mortar pharmacies as well as online stores. This offers an excellent opportunity to position products with a professional partner with an in depth understanding of the market dynamics in Ukraine. We have high aspirations for this collaboration, which we are convinced will be a springboard for further successful expansion into other adjacent countries.”
Pavlo Huzar, General Director of Deutsch-Pharm, added: “We are pleased to start this partnership with ProBiotix Health. This is another important step towards the implementation of our mission to provide consumers in Ukraine and other selected countries in the region with innovative, efficacious, and economically feasible products."
“We are increasingly building our product line, so the collaboration with ProBiotix is an important development for us. We are convinced that these products will help many people in Ukraine who are looking for a safe and effective way to solve the challenge of high cholesterol levels.”
